Finding a pathological diagnosis for Alzheimer's disease: Are inflammatory molecules the answer?

Glial cells in (patho)physiology

(2012) Vladimir Parpura et al.   JOURNAL OF NEUROCHEMISTRY

Extended results of the Alzheimer’s disease anti-inflammatory prevention trial

(2011) John C. Breitner et al.   Alzheimers & Dementia

Clusterin as an Alzheimer Biomarker

(2011) John Hardy   ARCHIVES OF NEUROLOGY

Systemic inflammation and Alzheimer's disease

(2011) Clive Holmes et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease

(2011) Sam-Moon Kim et al.   BMC Neurology

Histological and Direct Evidence for the Role of Complement in the Neuroinflammation of AD

(2011) Robert Veerhuis   Current Alzheimer Research

Complement activation as a biomarker for Alzheimer's disease

(2011) Mohammed Aiyaz et al.   IMMUNOBIOLOGY

Identification of a blood-based biomarker panel for classification of Alzheimer's disease

(2011) Christoph Laske et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Plasma Clusterin and the Risk of Alzheimer Disease

(2011) Elisabeth M. C. Schrijvers   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The projected effect of risk factor reduction on Alzheimer's disease prevalence

(2011) Deborah E Barnes et al.   LANCET NEUROLOGY

Association of CSF Biomarkers and Secondary Insults Following Severe Traumatic Brain Injury

(2011) Deborah M. Stein et al.   Neurocritical Care

Role of Interleukin 6 and Alpha-Globulins in Differentiating Alzheimer and Vascular Dementias

(2011) Azza A. Helmy et al.   Neurodegenerative Diseases

Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment

(2011) Madhav Thambisetty et al.   NEUROIMAGE

Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease

(2010) Madhav Thambisetty et al.   ARCHIVES OF GENERAL PSYCHIATRY

Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People

(2010) Geert De Meyer   ARCHIVES OF NEUROLOGY

A Meta-Analysis of Cytokines in Alzheimer's Disease

(2010) Walter Swardfager et al.   BIOLOGICAL PSYCHIATRY

The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease : experience from the first 24 months

(2010) Andrew Simmons et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

AddNeuroMed-The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease

(2009) Simon Lovestone et al.   Annals of the New York Academy of Sciences

Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels

(2009) Holly D. Soares et al.   Annals of the New York Academy of Sciences

Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease

(2009) John C. Morris et al.   ARCHIVES OF NEUROLOGY

Plasma biomarkers for mild cognitive impairment and Alzheimer's disease

(2009) Fei Song et al.   BRAIN RESEARCH REVIEWS

Clusterin: A forgotten player in Alzheimer's disease

(2009) Tapio Nuutinen et al.   BRAIN RESEARCH REVIEWS

Multiplex Analysis of Cytokines in the Serum and Cerebrospinal Fluid of Patients With Alzheimer's Disease by Color-Coded Bead Technology

(2009) Chulhee Choi et al.   Journal of Clinical Neurology

Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer’s disease

(2009) Madhav Thambisetty et al.   JOURNAL OF NEUROLOGY

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

(2009) Pieter Jelle Visser et al.   LANCET NEUROLOGY

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

(2009) Richard J. Perrin et al.   NATURE

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

(2009) Jean-Charles Lambert et al.   NATURE GENETICS

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

(2009) Denise Harold et al.   NATURE GENETICS

Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease

(2009) Josef Marksteiner et al.   NEUROBIOLOGY OF AGING

Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization

(2009) R. C. Petersen et al.   NEUROLOGY

CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases

(2008) Jing Zhang et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone

(2008) Emma L. Akuffo et al.   BIOMARKERS

Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration

(2008) D. Galimberti et al.   JOURNAL OF NEUROLOGY

Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease

(2008) Melanie Meyer-Luehmann et al.   NATURE

Biomarkers of Alzheimer's disease

(2008) Rebecca Craig-Schapiro et al.   NEUROBIOLOGY OF DISEASE

Structural and Quantitative Comparison of Cerebrospinal Fluid Glycoproteins in Alzheimer’s Disease Patients and Healthy Individuals

(2008) Carina Sihlbom et al.   NEUROCHEMICAL RESEARCH

Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma

(2008) Paul Cutler et al.   Proteomics Clinical Applications

Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease

(2007) Harald Hampel et al.   Alzheimers & Dementia